Ntla stock forecast

US $293.00
List price US $526.000 (16% off)
777 sold
This one's trending. 16293 have already sold.
Breathe easy. Returns accepted.

CGU et Politique de confidentialité Your Privacy Choices CA Privacy Notice More Info Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) just released its latest second-quarter results and things are looking bullish. Revenues were better than expected, with US$14m in revenue some 17% ahead of forecasts. The company still lost US$0.98 per share, although the losses were marginally smaller than the analysts expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. NTLA stock forecast probabilities from quantitative models indicate a 60% chance of trading above $38 in the next 90 days, assuming no adverse regulatory headlines.